首页> 外文期刊>Veterinary Research Communications >Clinical usefulness of peripheral blood lymphocyte subsets in canine lymphoma
【24h】

Clinical usefulness of peripheral blood lymphocyte subsets in canine lymphoma

机译:犬淋巴瘤外周血淋巴细胞亚群的临床有用性

获取原文
获取原文并翻译 | 示例
           

摘要

The classification of canine lymphoid malignancies into groups based on cell of origin (B- or T-cell types) is possible with immunophenotypic analysis. A high frequency of B-cell lymphomas has been described; about 30% of lyrnphomas are of T-cell origin (Teske et al., 1994a; Fournel-Fleury et al., 1997; Grindem et al., 1998). In human medicine the major diagnostic role of blood lymphocyte subset typing is the screening for non-Hodgkin's lymphomas with peripheral blood involvement and their differentation from reactive lymphoproliferative conditions (Thalhammer-Scherrer et al., 2000). The aim of this project is to evaluate the diagnostic efficacy of blood immunophenotyping in dogs with lymphoma in order to detect the blood involvement and the prognostic benefits.
机译:免疫表型分析可以对基于原产地(B型或T细胞类型)细胞的犬淋巴淋巴恶恶性分类。 已经描述了高频率的B细胞淋巴瘤; 约30%的葡萄球菌是T细胞来源(Teske等,1994a; Fournel-Fleury等,1997; Grindem等,1998)。 在人类中,血液淋巴细胞子集键入的主要诊断作用是对非霍奇金淋巴瘤的筛查,外周血受累及其与反应性淋巴抑制性条件的分解(Thalhammer-Scherrer等,2000)。 该项目的目的是评估血液免疫蛋白酶在淋巴瘤中血液免疫蛋白酶型的诊断疗效,以检测血液受累和预后益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号